| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/06/2003 | US20030027998 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cardiovascular, nervous system, cancer and infectious disorders |
| 02/06/2003 | US20030027987 Novel polypeptide from Haemophilus paragallinarum and process for preparing the same |
| 02/06/2003 | US20030027983 Transport protein for use in the treatment of blood, hypertensive and epileptic disorders |
| 02/06/2003 | US20030027981 Urokinase-type plasminogen activator receptor |
| 02/06/2003 | US20030027782 Method for treating allergic lung disease |
| 02/06/2003 | US20030027776 For detecting, therapy, prophylaxis and/or prognosing disorders related to the tissues where these cancer antigens are expressed |
| 02/06/2003 | US20030027774 For diagnosis and therapy of tuberculosis |
| 02/06/2003 | US20030027773 Protein-polycation conjugates |
| 02/06/2003 | US20030027766 Used in cancer therapy and production of potential anti-cancer vaccines |
| 02/06/2003 | US20030027749 For use in therapy, and diagnostic assays |
| 02/06/2003 | US20030027744 Use of a CD40:CD154 binding interruptor to treat immunological complications of the eye |
| 02/06/2003 | US20030027322 Genration of herpesvirus amplicon particle for use in the treatment of cancer; obtain nucleotide sequences, incubate with expression vectors, ligate recover viral vector |
| 02/06/2003 | US20030027321 Recombinant RSV virus expression systems and vaccines |
| 02/06/2003 | US20030027284 Tumor necrosis factor-gamma |
| 02/06/2003 | US20030027283 Protein l and hybrid proteins thereof |
| 02/06/2003 | US20030027261 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 02/06/2003 | US20030027253 Nucleotides equences codin polypeptide for use in the treatment of cancer |
| 02/06/2003 | US20030027246 Prostate protein for use in the diagnosis and treatment of cancer |
| 02/06/2003 | US20030027230 Detection of antiproliferative agents for treatment of ovarian cancer; obtain cells, incubate with modulator, monitor cells for reduction in cancer activity, reduction in cancer activity indicates antiproliferative agents |
| 02/06/2003 | US20030027198 Nucleotide sequences coding polypeptide for use in the treatment of tumors |
| 02/06/2003 | US20030027188 SLC7s as modifiers of the p53 pathway and methods of use |
| 02/06/2003 | US20030027181 Methods for the early diagnosis of ovarian cancer |
| 02/06/2003 | US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides |
| 02/06/2003 | US20030027144 Nucleotide sequences coding protein for use in the treatment cancer |
| 02/06/2003 | US20030027130 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of viral diseases |
| 02/06/2003 | US20030026814 EIAV P26 deletion vaccine and diagnostic |
| 02/06/2003 | US20030026813 Vaccine composition and method of using the same |
| 02/06/2003 | US20030026809 Stimulantion of immunological response |
| 02/06/2003 | US20030026808 Anticholesterol agents; cardiovascular disorders |
| 02/06/2003 | US20030026807 Immuno-potentiating systems for preparation of immunogenic materials |
| 02/06/2003 | US20030026805 Genetic engineering; monoclonal antibody grafted to tumor necrosis factor |
| 02/06/2003 | US20030026804 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 02/06/2003 | US20030026803 Compositions for inhibiting macrophage activity |
| 02/06/2003 | US20030026801 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 02/06/2003 | US20030026800 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 02/06/2003 | US20030026796 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase |
| 02/06/2003 | US20030026793 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 02/06/2003 | US20030026790 Activated dual specificity lymphocytes and their methods of use |
| 02/06/2003 | US20030026783 Method of modulating neutralizing antibodies formation in mammals, and uses thereof in gene therapy, animal transgenesis and in functional inactivation of an endogenous proteins |
| 02/06/2003 | US20030026782 Viricides |
| 02/06/2003 | US20030026777 Detection and treatment of breast disease |
| 02/06/2003 | US20030026764 Administering antibodies; anticancer agents |
| 02/06/2003 | CA2455360A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 02/06/2003 | CA2454920A1 Antigenic compositions |
| 02/06/2003 | CA2454824A1 Treatment of immune disorders and b cell disorders |
| 02/06/2003 | CA2454802A1 Novel class ii cytokine receptors and uses thereof |
| 02/06/2003 | CA2454734A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions |
| 02/06/2003 | CA2454562A1 Method of improving cognitive function |
| 02/06/2003 | CA2454517A1 Novel compounds |
| 02/06/2003 | CA2454469A1 Blood group antigen fusion polypeptides and methods of use thereof |
| 02/06/2003 | CA2453880A1 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 02/05/2003 | EP1281767A2 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 02/05/2003 | EP1281761A1 Hepatitis B virus pre-S1 derived synthetic polypeptides and their use thereof. |
| 02/05/2003 | EP1281760A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 02/05/2003 | EP1281758A2 Four human zinc-finger-containing proteins : MDZ3, MDZ4, MDZ7 and MDZ12 |
| 02/05/2003 | EP1281756A1 Regulator of calcineurin |
| 02/05/2003 | EP1281754A1 Hiv-producing cell line and use thereof |
| 02/05/2003 | EP1281404A2 Use of antibodies against the urokinase receptor |
| 02/05/2003 | EP1281083A1 Methods for detecting inflammation and inflammatory conditions |
| 02/05/2003 | EP1280914A1 Tt virus polypeptide, nucleic acid coding for said polypeptide and uses |
| 02/05/2003 | EP1280912A2 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 02/05/2003 | EP1280904A2 Pain signaling molecules |
| 02/05/2003 | EP1280903A2 Ph domain-interacting protein |
| 02/05/2003 | EP1280900A2 Dendritic cell co-stimulatory molecules |
| 02/05/2003 | EP1280899A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 02/05/2003 | EP1280898A1 Modified es cells and es cell-specific gene |
| 02/05/2003 | EP1280897A2 Regulation of nf-at interacting protein nip 45 variant |
| 02/05/2003 | EP1280828A2 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses |
| 02/05/2003 | EP1280826A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 02/05/2003 | EP1280551A2 Immunizing against hiv infection |
| 02/05/2003 | EP1280550A2 Electroporation for introduction of molecules into cells |
| 02/05/2003 | EP1280521A2 Vaccine composition, method of preparing the same, and method of vaccinating vertebrates |
| 02/05/2003 | EP1280518A2 Liposome drug delivery |
| 02/05/2003 | EP1280517A1 Beta-glucans encapsulated in liposomes |
| 02/05/2003 | EP1280516A1 Method for transdermal or intradermal delivery of molecules |
| 02/05/2003 | EP1280406A1 Vaccines, immunotherapeutics and methods for using the same |
| 02/05/2003 | EP0896583B1 Use of peptide fragments derived from osp-c for diagnostic methods |
| 02/05/2003 | EP0804231B1 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| 02/05/2003 | EP0574512B1 Redirection of cellular immunity by receptor chimeras |
| 02/05/2003 | CN1395617A A humanized antibody to surface antigen S of hepatitis B virus and preparing method thereof |
| 02/05/2003 | CN1395581A Recombinant antibodies to human IL-1 beta |
| 02/05/2003 | CN1394643A Medicine for curing subacute thyroiditis |
| 02/05/2003 | CN1394602A Benzoic acid substituted benzopyran fro curing atheroscleorsis |
| 02/05/2003 | CN1100876C DNA encoding human paplilloma virus type 18 |
| 02/05/2003 | CN1100788C Peptide for vaccine of schistosomiasis |
| 02/05/2003 | CN1100787C Peptide for vaccine of schisosomiasis |
| 02/05/2003 | CN1100569C Method for preparing tumour vaccinum |
| 02/05/2003 | CN1100568C Process for synthesizing protein immunoadsorbent medium for removing pathogenic antibody and its compounds from plasma |
| 02/04/2003 | US6514948 Method for enhancing an immune response |
| 02/04/2003 | US6514943 Method and composition for preserving viruses |
| 02/04/2003 | US6514942 Nonapeptide induces Her-2 peptide reactive cytotoxic T-lymphocytes |
| 02/04/2003 | US6514761 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 02/04/2003 | US6514758 Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy |
| 02/04/2003 | US6514754 Of herpesvirus of turkeys (HVT) inserted in a non-essential region of the vector; may be manipulated to provide vaccines |
| 02/04/2003 | US6514745 Oncoprotein protein kinase |
| 02/04/2003 | US6514726 Aspergillus fumigatus acetyl coenzyme-A carboxylase genes and polypeptides and uses thereof |
| 02/04/2003 | US6514697 Methods for detection of Crytosporidium species and isolates and for diagnosis of Cryptosporidium infections |
| 02/04/2003 | US6514696 Detection thereof; Using polynucleotide that hybridizes to given nucleotide sequence; Cancer |
| 02/04/2003 | US6514694 Detecting parasite oocysts in feces by contacting feces sample with a solid support capable of binding oocysts, dryin, washing, adding elution solution and eluting DNA from sample by heating, PCR amplification with primers |
| 02/04/2003 | US6514691 An antigenic envelope polypeptide of given amino acid sequence was identified |